Nilsson et al., 1975 - Google Patents

Intrauterine death and circulating anticoagulant (“antithromboplastin”)

Nilsson et al., 1975

Document ID
2014847950959170521
Author
Nilsson I
Åstedt B
Hedner U
Berezin D
Publication year
Publication venue
Acta Medica Scandinavica

External Links

Snippet

A report is presented of a young, otherwise apparently healthy, woman who had had three pregnancies which for some unknown reason terminated in intrauterine death (macerated foetuses). During the third pregnancy a coagulation defect was diagnosed, which was …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material

Similar Documents

Publication Publication Date Title
Nilsson et al. Intrauterine death and circulating anticoagulant (“antithromboplastin”)
Lechner Acquired inhibitors in nonhemophilic patients
BAKER et al. Hypofibrinogenemic hemorrhage in acute myelogenous leukemia treated with heparin: with autopsy findings of widespread intravascular clotting
Smith et al. Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature
Kociba Bovine plasma thromboplastin antecedent (Factor XI) deficiency
Holmberg et al. Coagulation in the human fetus: Comparison with term newborn infants
Roberts et al. A clinical and experimental study of acquired inhibitors to factor VIII
Åberg et al. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII
Svanberg et al. Abruptio placentae—treatment with the fibrinolytic inhibitor tranexamic acid
Singer et al. Pseudohemophilia type b: hereditary hemorrhagic diathesis characterized by prolonged bleeding time and decrease in antihemophilic factor
Soff et al. Familial multiple coagulation factor deficiencies
Sussman et al. Clinical application of simplified serum prothrombin consumption test
Rapaport et al. Consumption of serum factors and prothrombin during intravascular clotting in rabbits
Singer et al. Circulating anticoagulants in hemophilia and in hemophilia-like disease
HENSTELL et al. A new theory of interference with the clotting mechanism: the complexing of euglobulin with factor V, factor VII and prothrombin
Dische et al. Congenital factor VII deficiency. Haematological and genetic aspects
QUICK Menstruation in hereditary bleeding disorders
Triplett Platelet Disorders Douglas Triplett
RAMOT et al. Plasma Thromboplastin Antecedent: Deficiency
Ekelund et al. Fibrinolysis in human foetuses
Ratnoff et al. A hemorrhagic state during pregnancy: With the presence of maternal Rh antibodies, death of the fetus and hypofibrinogenemia
RATNOFF Antihemophilic factor (factor VIII)
Nilsson et al. A circulating anticoagulant against factor V
Bowman Acquired fibrinogenopenia
Chesney et al. A syndrome of platelet-release abnormality and mild hemophilia